Oramed Pharmaceuticals Inc.
ORMPNASDAQNASDAQ Capital Market·USD·Closed
$3.37
−$0.05 (1.46%)
$3.37
−$0.05 (1.46%)
Not investment advice.Learn more
ORMP has more going for it than against it right now.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Small-cap company
P/E Ratio
Cheap relative to earnings
Div Yield
Strong income stock